Actively Recruiting
STOP DIABETES - Knowledge-based Solutions
Led by University of Eastern Finland · Updated on 2017-05-17
10000
Participants Needed
1
Research Sites
1077 weeks
Total Duration
On this page
Sponsors
U
University of Eastern Finland
Lead Sponsor
N
National Institute of Health and Welfare
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of the Stop Diabetes - Knowledge based solutions (StopDia) consortium project (University of Eastern Finland, National Institute for Health and Welfare, and Technical Research Centre of Finland) is to develop and test approaches to identify individuals at increased risk of type 2 diabetes and to empower them in adopting and maintaining a healthy lifestyle by combining individual and environment level strategies into a dual-process approach targeting deliberative and automatic processes of behavior. We also aim to identify barriers and facilitators of adopting a healthy lifestyle in the society, create a model for the prevention of type 2 diabetes by joint actions of health care, third sector, and other societal actors, and develop methods to monitor the cost-effectiveness of these actions. We will carry out a 1-year randomized controlled trial on the effects of among 10 000 individuals aged 18-70 years at increased risk of type 2 diabetes living in Finland. The participants will be randomized into the control group, the digital lifestyle intervention group, or the combined digital and face-to-face lifestyle intervention group. The aim of the interventions is to enhance diet quality, increase physical activity, decrease body weight, and improve glucose tolerance in individuals at increased risk of type 2 diabetes.
CONDITIONS
Official Title
STOP DIABETES - Knowledge-based Solutions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 70 years
- Finnish diabetes risk score of 12 points or more, or previous gestational diabetes, or repeated impaired fasting glucose (6.1 - 6.9 mmol/l), or impaired glucose tolerance (2-hour glucose 7.8 - 11.0 mmol/l)
- Living in the hospital districts of Northern Savo, Päijät-Häme, or South Karelia in Finland
- Access to a computer, smartphone, or tablet with internet
- Having a personal mobile phone number
- Adequate Finnish language skills
You will not qualify if you...
- Diagnosis of type 1 or type 2 diabetes
- Currently pregnant or breastfeeding
- Current cancer or cancer treatment ended less than 6 months ago
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Eastern Finland
Kuopio, Finland
Actively Recruiting
Research Team
J
Jussi Pihlajamäki, MD, PhD
CONTACT
T
Timo A Lakka, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here